Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TP1148L |
Glucagon-like peptide 1 (1-37), human acetate
|
Glucagon Receptor | GPCR/G Protein |
Glucagon-like peptide 1 (1-37), human acetate 是一种高效的 GLP-1 受体激动剂。 | |||
TP1148 |
Glucagon-like peptide 1 (1-37), human
HuGLP-1 |
||
Glucagon-like peptide 1 (1-37), human is a highly potent agonist of the GLP-1 receptor.Pancreatic hormone synthesized by post-translational processing of proglucagon. Unlike truncated forms of GLP-1, it has no effect on food intake in rats and does not en | |||
TP1147 |
Glucagon-like peptide 1 (1-37), human TFA
HuGLP-1 TFA |
||
Glucagon-like peptide 1 (1-37), human (TFA) is a highly potent agonist of the GLP-1 receptor, it is a kind of pancreatic hormone synthesized by post-translational processing of proglucagon. | |||
T80453 |
GLP-1 (1-36) amide (human, rat)
Glucagon-like Peptide 1 (1-36) amide (human, rat) |
||
GLP-1(1-36) amide (human, rat)(人类及大鼠的胰高血糖素样肽1(1-36)酰胺)是GLP-1(7-36)酰胺的一种分子变体。该化合物能激发[14C]氨基吡啶在大鼠胃壁细胞的酶分散体中积累。 | |||
TP1157 |
GLP-2(1-33)(human)
GLP-2 (human),Glucagon-like peptide 2 (human) |
||
GLP-2(1-33) (human) is an enteroendocrine hormone which stimulates the growth of the intestinal epithelium. | |||
T82309 |
GLP-1 (1-36) amide (human, rat) (TFA)
Glucagon-like Peptide 1 (1-36) amide (human, rat) (TFA) |
||
GLP-1(1-36) amide (human, rat) TFA为胰高血糖素样肽1(GLP-1)-(7-36)酰胺的分子变体,能够促进[14C]氨基吡啶在大鼠壁细胞的酶分散体中的积累。 | |||
T3984 |
GLP-1(7-36), amide
MKC 253,胰高血糖素样肽-1,Human GLP-1-(7-36)-amide,Glucagon-like Peptide 1 (7-36) amide,Glucagon-Like Peptide (GLP) I (7-36), amide, human,GLP-1(7-36),GLP-1-(7-36)-amide |
Glucagon Receptor | GPCR/G Protein |
GLP-1(7-36), amide (MKC 253) 是一种生理性肠降血糖素,能够刺激胰岛素分泌。 | |||
T76330 |
Human glucagon-like peptide-1-(7-36)-Lys(Biotin) amide
|
||
Human glucagon-like peptide-1-(7-36)-Lys(Biotin) amide 是一种带有生物素标签的Glucagon-like peptide-1-(7-36),后者为一种具备提升胰岛素释放功能,从而表现出抗糖尿病活性的胃肠道肽。 | |||
T76085 |
Glucagon-Like Peptide 1 (GLP-1) (7-36)-Lys (Biotin), amide, human
|
||
Glucagon-Like Peptide 1 (GLP-1) (7-36)-Lys (Biotin), amide, human 是一种被 C 端标记的生物素化 GLP-1(7-36) 酰胺。 | |||
T36579 |
GLP-1R Agonist DMB
|
Glucagon Receptor | GPCR/G Protein |
GLP-1R Agonist DMB 是胰高血糖素样肽1受体的激动剂(GLP-1R;重组人受体的 KB=26.3nM)。 | |||
T19850 |
Semaglutide
索玛鲁肽,司美格鲁肽,索马鲁肽 |
Glucagon Receptor | GPCR/G Protein |
Semaglutide 是人胰高血糖素样肽-1受体激动剂,是一种人胰高血糖素样肽-1 的长效类似物。它有用于 2 型糖尿病研究的潜力。 | |||
T36428 |
PACAP-related Peptide (human) (trifluoroacetate salt)
|
PACAP | GPCR/G Protein |
PACAP-related peptide (PRP) is an endogenous 29-amino acid peptide that belongs to the secretin/glucagon superfamily of peptides, which includes secretin , glucagon , glucagon-like peptide-1 , GLP-2 , and pituitary adenylate cyclase-activating polypeptide . It is expressed in normal human pancreas and adrenal gland tissue and in some tumors that produce vasoactive intestinal peptide (VIP). PRP (1-29) is secreted by CHO-K1 cells that express human recombinant preproPACAP. | |||
T80565 |
Gulgafafusp alfa
|
||
Gulgafafusp alfa 为人源化IgG2κ类抗体,专一性靶向GLP1R(胰高血糖素样肽1受体)。 | |||
T36072 |
Skyrin
Endothianin,Rhodophyscin |
||
Skyrin is a fungal metabolite characterized by a bisanthraquinone structure. It interferes with glucagon signaling through adenylate cyclase without binding to the glucagon receptor. At 10 μM, skyrin reduces both glucagon-stimulated cAMP production and glycogenolysis. It does not interfere with epinephrine or glucagon-like peptide 1 effects on these parameters.[1] Reference:[1]. Parker, J.C., McPherson, R.K., Andrews, K.M., et al. Effects of skyrin, a receptor-selective glucagon antagonist, in r... | |||
T75822 |
GLP-1(9-36)amide TFA
|
||
GLP-1(9-36)amide TFA, 作为胰高血糖素样肽-1 (7-36)amide的主要代谢产物,是人胰腺GLP-1受体的拮抗剂。 | |||
T36380 |
GLP-1 (1-36) amide (human, rat) (trifluoroacetate salt)
|
||
GLP-1 amide is a peptide hormone cleaved from proglucagon in the pancreas.1,2 Mice lacking the glucagon receptor (Gcgr-/-) have approximately nine-fold higher levels of total GLP-1 amide, including GLP-1 (1-36) amide and truncated GLP-1 (7-36) amide , in pancreatic tissue compared to wild-type mice.2References1. Schjoldager, B.T., Mortensen, P.E., Christiansen, J., et al. GLP-1 (glucagon-like peptide 1) and truncated GLP-1, fragments of human proglucagon, inhibit gastric acid secretion in humans... | |||
T80084 |
Retatrutide acetate
LY3437943 acetate |
||
Retatrutide (LY3437943) acetate 是一种针对胰高血糖素受体(GCGR)、葡萄糖依赖性促胰岛素多肽受体(GIPR)和胰高血糖素样肽-1 受体(GLP-1R)的三重肽激动剂。该化合物能有效抑制这三种受体,其EC50值分别为GCGR 5.79 nM、GIPR 0.0643 nM和GLP-1R 0.775 nM,是肥胖研究领域的潜在工具。 | |||
T76333 |
(Ser8)-GLP-1 (7-36) amide, human
|
||
(Ser8)-GLP-1 (7-36) amide, human 为源自胰高血糖素原的胰高血糖素样肽-1酰胺,属于 GLP-1(1-36) 酰胺肽裂解产物。作为肠促胰岛素激素,该化合物促进胰腺 β 细胞在葡萄糖依赖性条件下分泌胰岛素,并对消化道的运动与分泌功能产生影响。 | |||
T21691 |
NVP DPP 728 dihydrochloride
|
||
NVP-DPP728 是一种有效、可逆、腈依赖性二肽基肽酶 IV (DPP-IV)抑制剂,Ki 值为 11 nM。NVP-DPP728 可抑制胰高血糖素样肽-1 (GLP-1)的降解,从而增强响应于葡萄糖摄入的胰岛素释放。NVP-DPP728 可用于糖尿病研究。 | |||
T73694 |
Albiglutide TFA
|
||
Albiglutide TFA 是一种胰高血糖素样肽GLP-1模拟物,是长效的GLP-1受体激动剂。Albiglutide TFA 可显著降低糖化血红蛋白 (A1C)。Albiglutide TFA 可用于研究 2 型糖尿病 (T2D)。Albiglutide TFA 是由抗DPP-4的GLP-1二聚体与人白蛋白的基因融合产生的。 | |||
T83906 |
Tirzepatide sodium
LY3298176 |
||
Tirzepatide 是一种glucagon-like peptide 1 receptor (GLP-1R) 和 G protein-coupled receptor 119 (GPR119)的激动剂。它在表达人类GLP-1R或GPR119的HEK293细胞中诱导cAMP的产生(EC50s分别为6.54和1.01 nM)。Tirzepatide(100 nM)在表达人类GLP-1R或GPR119的HEK293细胞中诱导受体内化。在体内,Tirzepatide(每天10 nmol/kg)降低高脂饮食诱导的肥胖小鼠模型的体重、食物摄入量、血浆leptin、三酸甘油酯和free fatty acids (FFAs)水平、肝脏三酸甘油酯和血糖水平。它通过每三天给药50 nmol/kg的剂量,阻止A. alternata诱导的A. alternata挑战小鼠的支气管肺泡灌洗液(BALF)中嗜酸性粒细胞和淋巴细胞数量的增加。Tirzepatide(每三天50 nmol/kg)抑制由毒蕈碱受体激动剂methacholine (acetyl-β-methylcholine)导致的在糖尿病诱导的哮喘... |